Journal of Postgraduate Medicine, Education and Research

Register      Login

VOLUME 56 , ISSUE 4 ( October-December, 2022 ) > List of Articles


A Brief Report on the Prevalence of Vitamin D3 Deficiency in Children with Brain Tumors

Navneet Singla, Kokkula Praneeth, Ashish Aggarwal

Keywords : Brain tumors, Deficiency, Vitamin D

Citation Information : Singla N, Praneeth K, Aggarwal A. A Brief Report on the Prevalence of Vitamin D3 Deficiency in Children with Brain Tumors. J Postgrad Med Edu Res 2022; 56 (4):171-173.

DOI: 10.5005/jp-journals-10028-1600

License: CC BY-NC 4.0

Published Online: 31-12-2022

Copyright Statement:  Copyright © 2022; The Author(s).


Introduction: For both benign and malignant brain tumors, the outcome continues to remain dismal despite the progress made in the last half a century. The picture is gloomier in the pediatric age-group. As for any disease with limited survival and high morbidity, it is imperative to study the disease etiology to have meaningful interventions. Apart from genetics that cannot be modified, environmental and dietary factors play a role in oncogenesis, and these are potentially modifiable. A lesser-studied aspect is the role of micronutrients in the causation of brain tumors, especially in early childhood. We analyzed the association of vitamin D3 (Vit D3) in children with brain tumors. Methods and materials: A prospective study of 50 children diagnosed with brain tumors in early childhood (<5 years old) was carried out. Vit D3 levels were measured in the blood samples of these patients and their mothers. A correlation was established between levels of Vit D3 and brain tumors. Results: Around 26 children (52%) with pediatric brain tumors (PBTs) had Vit D3 deficiency. Of the 50 patients whose mothers were also analyzed, 22 (44%) mothers had Vit D3 deficiency. Interestingly, out of 26 children with Vit D3 deficiency, 17 were those whose mothers were also having hypovitaminosis D3. If the mother is deficient in Vit D3, the odds ratio for a child to be deficient in Vit D3 is 7.2 Conclusion: Large majority of children with brain tumors and their mothers were found to have a deficiency of Vit D3. Further large studies are required before any meaningful prevention strategy can be formulated.

  1. Lau SK, Chen YY, Chen WG, et al. Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 2005;18(6):838–843. DOI: 10.1038/modpathol.3800352
  2. Moulder JE, Foster KR, Erdreich LS, et al. Mobile phones, mobile phone base stations, and cancer: a review. Int J Radiat Biol 2005;81(3):189–203. DOI: 10.1080/09553000500091097
  3. Shirai T, Kawabe M, Ichihara T, et al. Chronic exposure to a 1.439 GHz electromagnetic field used for cellular phones does not promote N-ethylnitrosourea induced central nervous system tumors in F344 rats. Bioelectromagnetics 2005;26(1):59–68. DOI: 10.1002/bem.20079
  4. Naveilhan P, Berger F, Haddad K, et al. Induction of glioma cell death by 1,25(OH)2 vitamin D3: towards an endocrine therapy of brain tumors? J Neurosci Res 1994;37(2):271–277. DOI: 10.1002/jnr.490370212
  5. Dietrich M, Block G, Pogoda JM, et al. A review: dietary and endogenously formed N-nitroso compounds and risk of childhood brain tumors. Cancer Causes Control 2005;16(6):619–635. DOI: 10.1007/s10552-005-0168-y
  6. Milne E, Greenop KR, Bower C, et al. Maternal use of folic acid and other supplements and risk of childhood brain tumors. Cancer Epidemiol Biomark Prev 2012;21(11):1933–1941. DOI: 10.1158/1055-9965.EPI-12-0803
  7. Greenop KR, Miller M, de Klerk NH, et al. Maternal dietary intake of folate, and vitamins B6 and B12 during pregnancy and risk of childhood brain tumors. Nutr Cancer 2014;66(5):800–809. DOI: 10.1080/01635581.2014.916326
  8. Wu X, Hu W, Lu L, et al. Repurposing vitamin D for treatment of human malignancies via targeting tumor microenvironment. Acta Pharm Sin B 2019;9(2):203–219. DOI: 10.1016/J.APSB.2018.09.002
  9. Bilani N, Elson L, Szuchan C, et al. Newly-identified pathways relating vitamin D to carcinogenesis: a review. In Vivo 2021;35(3):1345–1354. DOI: 10.21873/invivo.12387
  10. Bernhardt SM, Borges VF, Schedin P. Vitamin D as a potential preventive agent for young women's breast cancer. Cancer Prev Res (Phila) 2021;14(9):825–838. DOI: 10.1158/1940-6207.CAPR-21-0114
  11. Gesmundo I, Silvagno F, Banfi D, et al. Calcitriol inhibits viability and proliferation in human malignant pleural mesothelioma cells. Front Endocrinol (Lausanne) 2020;11:559586. DOI: 10.3389/fendo.2020.559586
  12. Jeon SM, Shin EA. Exploring vitamin D metabolism and function in cancer. Exp Mol Med 2018;50(4):1–14. DOI: 10.1038/s12276-018-0038-9
  13. Uhmann A, Niemann H, Lammering B, et al. Calcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma. Sarcoma 2012:2012:357040. DOI: 10.1155/2012/357040
  14. Eelen G, Gysemans C, Verlinden L, et al. Mechanism and potential of the growth-inhibitory actions of vitamin D and analogs. Curr Med Chem 2007:14(17):1893–1910. DOI: 10.2174/092986707781058823
  15. Ingham PW, McMahon AP. Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001:15(23):3059–3087. DOI: 10.1101/gad.938601
  16. Pak E, Segal RA. Hedgehog signal transduction: key players, oncogenic drivers, and cancer therapy. Dev Cell 2016;38(4):333–344. DOI: 10.1016/j.devcel.2016.07.026
  17. Zavala G, Prieto CP, Villanueva AA, et al. Sonic hedgehog (SHH) signaling improves the angiogenic potential of Wharton's jelly-derived mesenchymal stem cells (WJ-MSC). Stem Cell Res Ther 2017;8(1):203. DOI: 10.1186/s13287-017-0653-8
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.